Fresolimumab | Interleukin Related interleukin-related.com

Product Name :
Fresolimumab

Search keywords :
Fresolimumab

drugId :
null

Target Vo:
Transforming growth factor beta

Target Vo Short Name :
TGF-β

Moa_Name:
Transforming growth factor beta inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Cambridge Antibody Technology

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Primary Myelofibrosis

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-IGF1 Receptor (Tyr1166) Rabbit mAb supplier
SIRT3 Rabbit mAb In Vitro
TSG101 Antibody: TSG101 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to TSG101. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts